alexa Synthesis Of Some Novel 2-pyrazolyl-4(3H)-quinazolinone Derivatives Of Potential Antimalarial And Anti-leishmanial Activities
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

International Congress on Bacteriology & Infectious Diseases
November 20-22, 2013 DoubleTree by Hilton Baltimore-BWI Airport, MD, USA

Addisu Asfaw Azene
Accepted Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.004
Abstract
In this work, some novel 2-pyrazolyl-4(3H)-quinazolinone derivatives have been synthesized by cyclization and condensation reactions. The synthesized compounds were obtained in a good yield (55.9-94%). The chemical structures of the final compounds were also verified by spectroscopic tools (IR, 1H NMR and elemental microanalyses). The in vivo anti-malarial activity of these compounds against P.berghei infected mice was found to be moderate at oral dose of 48.46 μmol/kg/day. This dose is equivalent to 25 mg/kg of chloroquine phosphate which causes 100% inhibition of the parasite. Among the synthesized compounds, 2-(3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-5-yl)-3-phenylquinazolin-4(3H)-one, Xa, showed better activity with percent suppression of 65.89. The synthesized compounds were also evaluated for their in vitro anti-leishmanial activity against L. donovani. Among the synthesized compounds, compound IXe (IC50=0.0121 μg/ml) was found to be four times more potent than amphotericine B (IC50=0.0460 μg/ml) while it was two hundred sixty four (264X) times more potent than miltefosine (IC50=3.1911 μg/ml). Compound Xa (IC50=0.0211 μg/ml) was twice more potent than amphotericine B and this is the second most active compound as anti-leishmanial agent among the synthesized compounds. The synthesized compounds exhibited better inhibitory activity as indicated by their lower IC50 than miltefosine, except for compound XI. Compound XI showed the least activity which might be due to the presence of a phenyl group on the pyrazole N1. Furthermore, in the thiophen series cyclization of α,β-unsaturated compounds to the corresponding pyrazoline analogs led to improvement in activity while the phenyl series showed conflicting results. Results of acute toxicity test of the most active compounds (IXe and Xa) showed that the median lethal dose (LD50) is much greater than 300 mg/kg.
Biography
Addisu Asfaw Azene has completed his B.Pharm at the age of 23 years from University of Gondar, School of Pharmacy and M.Sc. in Medicinal Chemistry from Addis Ababa University, School of Pharmacy. He is lecturer and researcher at Mekelle University, Ethiopia. He has conducted different researches awaiting publication on reputed journals.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords